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An Association Study of the A218C Polymorphism of the   
Tryptophan Hydroxylase 1 Gene with Eating Disorders   
in a Korean Population: A Pilot Study 
 
 
 
ObjectiveaaWe examined the association between the tryptophan hydroxylase 1 (TPH1) gene 
and eating disorders focusing on obsessionality.   
MethodsaaThe sample included 62 women with a lifetime diagnosis of anorexia nervosa 
(AN) as well as 50 women with a lifetime diagnosis of bulimia nervosa (BN) recruited from 
specialist clinics for eating disorders and 131 healthy women in Korea. Blood samples were 
collected from all participants for the TPH1 genotyping. The patients were ad ministered the 
Korean version of the Eating Disorders Examination and obsessionality was conceptualized 
using measures of persistence, harm avoidance, and obsessive-compulsive symptoms.   
ResultsaaIn the case-control comparisons, the frequency of the A/A genotype was increased 
in the patients with BN, but this difference was not significant after correcting for multiple 
testing. We found no effect of the TPH A218C polymorphism on obsessionality in the patients 
with AN or BN.   
ConclusionaaAlthough the present findings should be regarded as preliminary because of 
the small size of our sample, they suggest that the TPH1 gene may contribute to the genetic 
susceptibility to BN and be associated with the other unexplored traits of bulimic case status.
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Introduction 
 
There is compelling evidence to suggest that eating disorders are marked by a
disturbance in the serotonergic system, in which the synthesis of 5-HT is one of the 
key processes. Furthermore, individuals at risk of developing bulimia nervosa (BN)
have trait abnormalities in the regulation of their brain serotonin function that might 
increase their vulnerability to dieting-induced decreases in plasma tryptophan.
1 The 
gene responsible for 5-HT synthesis, the tryptophan hydroxylase gene (TPH), is a plau-
sible candidate for susceptibility to eating disorders. Recently, several separate lines of 
biological evidence have emerged, which suggest that TPH1 may play an important 
role in modulating serotonergic function in the brain.
2-4 Moreover, the level of messen-
ger RNA (mRNA) of the TPH1 gene is similar to or higher than that of TPH2 in the 
brain regions involved in the modulation of both the feeding and emotional aspects
of behaviour, such as the cortex, thalamus, hippocampus, amygdala, and hypothal-
amus areas.
5 This biological evidence together with a recent genetic association study
on BN
6 point to the involvement of TPH1 in various psychiatric conditions including
eating disorders. 
In a large multicentre genetic study, obsessionality was selected as an important
trait for linkage analysis in eating disorders.
7 Obsessionality is a salient personality 
feature of individuals with eating disorders
8,9 and is a heritable trait.
10 Family studies  
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have reported the increased prevalence of obsessive com-
pulsive disorder and obsessive compulsive personality dis-
order in relatives of individuals with eating disorders.
11 
Persistence, which is a cognitive component of obsess-
ionality,
12 is suggested to be a part of the eating disorder 
endophenotype.
13 The 5-HT system has been strongly im-
plicated in the regulation of obsessional behavior
14 or cog-
nitive inflexibility.
15 
Therefore, we investigated whether a genetic variant of 
the TPH1 gene is associated with eating disorders with par-
ticular emphasis on obsessionality. In the absence of any 
available functional polymorphism in the coding region of 
the TPH1 gene, the intron 7 A218C polymorphism has been 
one of the most widely studied polymorphisms in the TPH1 
gene and might affect the expression of TPH1.
16  
In the present study, the first aim was to investigate 
whether the TPH1 A218C polymorphism was associated 
with eating disorders using a case-control design. Another 
related objective was to explore the association between 
the psychopathology of obsessionality and eating disorders 
and the TPH1 A 218C polymorphism using psychological 
measurements. 
 
Methods 
 
Study population 
A total of 243 individuals, comprising women with AN 
(n=62), women with BN (n=50), and healthy women (n= 
131), were included in this study. All of the patients were 
native Koreans, recruited between 2006 and 2008 from 
two specialist treatment centers for eating disorders in Korea. 
The patients with eating disorders had a diagnosis of AN 
or BN according to the Diagnostic and Statistical Manual of 
Mental Disorders 4th edition (DSM-IV) criteria.
17 Lifetime 
diagnoses on the basis of the hierarchical model of diag-
nosis adapted from a previously reported genetic study
18 
were determined for each patient. The life-time diagnosis 
was made using selected behavioural items, information re-
garding the current weight and height, and the current and 
past menstrual functioning items of the Eating Disorders 
Examination Questionnaire (EDE-Q)19- Korean version. In 
the individuals with AN, 34% (n=21) reported restricting 
type and 66% (n=41) reported binge purging type. Of the 
patients, 42 women with AN and 30 women with BN 
(67.2%) were administered the Korean version of the Eat-
ing Disorders Examination Interview (EDE)20 by a psy-
chologist (S-J.L.) and had their behavioural traits of obses-
sionality assessed. There was no difference between the gen-
otyping only group and the assessment completed group 
in terms of their demographic and clinical data {age, body 
mass index (BMI), duration of illness, depression and anx-
iety}(data available on request).  
The healthy controls were recruited by advertisement 
from among the residents of Korea after careful screening 
for a current or past history of eating disorders using the 
EDE-Q adapted to capture episodes of eating disorders in 
their lifetime and for a personal history of neuropsychiatric 
disorders. For all participants, the measured weight and 
height were obtained at the time of assessment, and the 
highest and lowest ever BMI were determined. This study 
was approved by the Institutional Review Board of Seoul 
Paik Hospital. Written informed consent was obtained from 
all participants.   
 
Measures 
The EDE was used to capture the eating disorder pathol-
ogy in patients using the restraint, eating concern, weight 
concern, and shape concern subscales. Obsessionality was 
conceptualized using traits of persistence and harm avoid-
ance, and obsessive-compulsive symptoms. Persistence and 
harm avoidance were assessed with the Korean version of 
the Temperament and Character Inventory (TCI).
21,22 Ob-
sessive-Compulsive symptoms were measured by both a 
clinicians rating assessment using a composite score for 
the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)23 
and self-rating scales using the Korean version of the Ma-
udsley Obsessive-Compulsive Inventory (MOCI).
24 The 
level of depression and anxiety in all of the patients was 
assessed using self-report instruments including the Korean 
versions of the Beck Depression Inventory (BDI)25 and 
the State and Trait Anxiety Inventory (STAI).
26  
  
Genotyping  
Genomic DNA was extracted from blood leukocytes 
using a DNA extraction kit (ABI, Foster City, CA, USA). 
Genotyping of the TPH polymorphism (A218, rs1800532) 
was carried out using an ABI PRISM SNaP Shot Multiplex 
kit and an ABI Prism 3730xl DNA analyzer (ABI, Foster 
City, CA, USA) according to the manufacturer’s recommen-
dations. The primers used for PCR were: sense, 5’-CATGT 
TCCATGCTCTATATGTGT-3’ and antisense, 5’-TGTCT 
GATTTTTTTCAGTGTTACATT-3’. The PCR conditions 
were as follows: 10 min at 95℃ for 1 cycle, and 30 cycles 
each at 95℃ for 30s, 55℃  for 1 min, 72℃  for 1 min fol-
lowed by 1 cycle at 72℃  for 7 mins. After amplification, the 
PCR products were treated with 1 unit each of shrimp alka-
line phosphatase (Roche) and exonuclease I (USB Corpo-
ration) at 37℃ for 60 minutes and 72℃ for 15 minutes. 
One μL of the polymerase chain reaction (PCR) products 
was added to a SNaPshot Multiplex Ready reaction mix-
ture containing 0.15 pmols of the genotyping primer of 5’-
TTATTAATTGACAACCTATTAGGTG-3’ for the primer 
extension reaction. The results were analyzed using Gene-
Scan analysis software (ABI, Foster City, CA, USA).  
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Statistical analyses 
First, case-control genetic comparisons were designed 
to evaluate the differences in the genotype and allele fre-
quencies by the chi-square test for the healthy controls and 
patients (AN or BN). Next, a multivariate analysis of var-
iance  (MANOVA) was computed for the patients with 
AN or BN by integrating the four subscales of EDE or the 
composite measurements of obsessionality which com-
prise the Y-BOCS and the MOCI, as well as the two sub-
scales of the TCI, persistence and harm avoidance, and 
the genotype as an independent variable. The MANOVA 
was followed by a univariate analysis. p values <0.05 were 
considered to be indicative of statistical significance, and 
two-tailed tests were used. A Bonferroni correction was 
applied if multiple testing was used. All statistical tests 
were performed with SPSS version 11.0.   
 
Results  
 
Clinical characteristics 
No difference was found between the groups with re-
spect to age, but the body mass index BMI {wt (kg)/ht 
(m)2}, differed between the groups as expected (Table 1). 
In the post hoc analysis, the current BMIs of the BN group 
and controls were similar. The BN group had a higher “high-
est ever BMI” than the control group. The AN group had 
the lowest “lowest ever BMI”, while that of the BN group 
was lower than that of the control group. The participants 
with eating disorders reported moderate levels of depres-
sion and anxiety and the BN group reported being more de-
pressive than the AN group.   
 
Tryptophan hydroxylase 1 A218C polymorphism 
and eating disorders with case-control  
comparison 
The genotype and allele frequencies of the variants in 
the participants with AN and BN and controls are shown 
in Table 2. The TPH1 A218C genotype distribution was 
in Hardy-Weinberg equilibrium in the patients with eating 
disorders and healthy participants (χ2=2.01, df=2, p=0.16), 
BN (χ2=1.77, df =2, p=0.18) and AN (χ2=0.54, df=2, p= 
0.46). As shown in Table 2, there were no differences in 
the TPH1 A218C allele/genotype frequency between the 
healthy controls and the individuals with AN. There was 
evidence of an association between the A/A genotype and 
BN, which was not statistically significant after correc-
tion for multiple testing.   
 
Tryptophan hydroxylase 1 A218C polymorphism 
and psychopathologies for eating disorders and 
obsessionality in eating disorders 
A MANOVA was computed for the patients with eating 
disorders by integrating the four EDE subscales or the com-
posite measurements for obsessionality. We could not find 
TABLE 2. Frequency of genotypes and alleles for the TPH1 A218C gene in healthy women and women with eating disorders 
Genotype    Allele 
A/A A/C C/C  Analysis    A C Analysis   
N  % N  %  N  %  χ2 (df=2)  p    N  % N  %  χ2 (df=1)  p 
Healthy women (N=131)   23  18  73  56  35  27       119  45 143 55     
E a t i n g   d i s o r d e r s                          
Women with anorexia nervosa (N=62) 15  24  28  45  19  31  2.07 0.360    058  47  066 53  0.06  0.800 
Women with bulimia nervosa (N=50) 18  36  20  40  12  24  7.28 0.026    056  56  044 44  3.24  0.072 
For comparison of eating disorders (anorexia nervosa or bulimia nervosa) patients with healthy controls. Because multiple comparisons 
were made, the Bonferroni-corrected significance level was set to alpha=0.05/2 (p<0.025)   
TABLE 1. Characteristics of samples  
Eating disorders  Analysis 
 
Healthy women 
(N=131)  Women with lifetime   
anorexia nervosa (N=62) 
Women with lifetime   
bulimia nervosa (N=50) 
F or t (df) p 
Age (years) 23.0  (03.4)  0022.6 (06.8)  023.1 (03.9) F  (2/240)=11.8  <0.84 
Age at onset (years) -  -  0018.1 (04.6)  019.1 (03.5) t  (110)=1.3  <0.21 
Body mass index (kg/m2)          
Current 20.5  (02.3)  0016.9 (03.2)  020.6 (02.0) F  (2/240)=90.9 <0.01 
Lowest ever  18.9 (02.1)  0014.4 (01.8)  018.2 (01.9) F  (2/240)=183.3  <0.01 
Highest ever  22.4 (03.2)  0021.6 (02.9)  024.2 (03.0) F  (2/240)=26.9 <0.01 
Beck depression inventory  07.1 (06.6)  0019.4 (13.1)  022.0 (11.8) F  (2/240)=64.4 <0.01 
State & Trait Anxiety Inventory  082.2 (19.0)  0105.3 (25.7) 109.7  (26.2) F  (2/240)=39.3 <0.01 
Data were shown as mean (SD)  
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any effect of genotype on the psychopathologies for eating 
disorder or obsessionality in either the patients with lifetime 
AN (EDE; F=1.04, df=8/74, p=0.42; obsessionality; F= 0.99, 
df=8/74, p=0.46) or those with lifetime BN (EDE; F=1.60, 
df=8/50, p=0.15; obsessionality; F=0.43, df=8/50, p=0.89). 
In the subsequent detailed univariate analysis designed 
to test for genotype effects (Table 3), there were no ef-
fects of genotype on the EDE subscales or on any of the 
measurements for obsessionality. 
 
Discussion 
 
In this study, a modest association between the A218C 
genotype of the THP1 gene and BN was found, although 
the significance was abolished after a correction for mul-
tiple testing was applied. This finding shows that the pos-
sibility of there being an association between TPH1 and 
bulimic case status cannot be excluded. There was no sig-
nificant effect of the A218C genotype of the THP1 gene 
on the psychopathologies for eating disorders or obses-
sionality in the analysis focusing on this issue. 
The increased prevalence of the AA genotype in BN 
could be explained by interactions of the THP1 gene with 
other genes responsible for the serotonergic function in 
this population. While TPH2 is considered to control 5-
HT synthesis in the brain,
27 recent studies suggest that the 
TPH1 and TPH2 genes may be coordinately expressed to 
regulate serotonergic function.
28,29 In addition, Ono et al.
2 
argued that the single nucleotide polymorphisms (SNPs) 
of the THP1 gene might affect the regulation of the 5-
HT2A receptor by producing changes in TPH activity, based 
on their finding that the AA genotype of the A218C SNP 
was associated with a lower 5-HT2A receptor density, which 
is of interest in eating disorders, because it has been im-
plicated in the modulation of feeding
30,31 and women who 
recovered from BN had reduced 5-HT2A receptor binding 
potential relative to controls.
14 Lastly, the A218C SNP 
might be associated with the turnover of 5-HT via almost 
complete linkage disequilibrium (LD) with the A779C 
SNP, whose genotype was reported to be associated with 
a blunted prolactin response to fenfluramine and low levels 
of cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid 
(5-HIAA),
32 which in turn is associated with BN.
33 Our 
results may reflect the existence of a broken link in the, 
genetically or functionally, tightly coordinated regulation 
of the serotonergic function or just one of several malfunc-
tional SNPs that could collectively perturb serotonergic 
function. 
From the finding that there was no significant effect of 
the A218C genotype of the THP1 gene on the psycho-
pathology for the disorder or obsessionality, it is notewor-
thy that the A218C polymorphism has an association with 
other unexplored behavioral traits in this study, such as 
aggression and anger-related traits
34-36 which are strongly 
suspected of being personality traits associated with BN.
37 
Therefore, the association between TPH1 and these traits 
needs to be explored in BN in the future.       
We need to consider that the A218C SNP is not the 
sole determinant of the functionality of the TPH1 gene, 
because it is in LD with putative functional SNPs in the 
promoter region, such as A-1067G and G-347T,
16 as well 
as other intron SNPs.
36 As our results show that the A218C   
SNP alone is not a major genetic risk factor for eating 
disorders, the analysis of the effect of the haplotypes and, 
more importantly, of the functionality of each haplotype, 
on the expression of the THP1 gene is required to clarify 
TABLE 3. Mean scores for the Eating Disorders Examination Interview or obsessionality as a function of TPH genotype in women with eat-
ing disorders 
  Lifetime anorexia nervosa  Lifetime bulimia nervosa 
  Genotypic distribution  Analysis  Genotypic distribution  Analysis 
 AA  (N=9)  AC (N=19) CC  (N=14)  F (df=2/39)  p  AA (N=10)  AC (N=16) CC  (N=4) F  (df=2/27)  p 
EDE  subscales               
Restraint 14.0  (07.7)  12.1 (06.9) 12.8  (08.9)  0.19 0.83  09.9 (6.4)  14.2 (07.6) 14.5  (01.9) 1.37  0.27 
Eating concern  13.1 (08.8)  14.4 (08.1) 20.1  (08.0)  2.64 0.08  16.1 (6.4)  19.1 (09.0) 16.0  (08.5) 0.51  0.61 
Weight concern  18.6 (13.0)  22.6 (11.3) 28.6  (12.0)  2.09 0.14  40.5 (5.0)  33.6 (12.1) 36.3  (11.2) 1.43  0.26 
Shape concern  10.1 (05.8)  11.1 (05.5) 14.5  (04.9)  2.39 0.11  15.6 (5.8)  14.1 (06.0) 16.0  (06.7) 0.27  0.77 
Obsessionality               
TCI_persistence  04.8 (01.7)  05.1 (01.9)  04.1 (01.8)  0.55 0.58  03.8 (2.3)  04.8 (01.5)  04.0 (01.6) 0.70  0.51 
TCI_harm avoidance  23.8 (08.8)  17.9 (09.4) 22.6  (06.0)  1.07 0.36  22.3 (8.7)  19.3 (09.8) 23.0  (07.1) 0.33  0.72 
Y-BOCS 16.1  (07.2)  13.7 (06.1) 15.3  (08.4)  0.47 0.63  11.6 (4.4)  12.0 (07.2) 10.8 (07.8) 0.05  0.95 
MOCI  07.9 (04.5)  10.4 (06.6) 11.1  (05.7)  0.78 0.47  06.4 (4.3)  06.2 (03.3)  09.0 (05.9) 0.67  0.53 
Data were shown as mean (SD). Analysis by univariate ANOVA for the effect of genotype on subscales of the EDE or each measure-
ment for obsessionality. EDE: Eating Disorders Examination Interview, TCI: Temperament And Character Inventory, Y-BOCS: Yale-Brown 
Obsessive Compulsive Scale, MOCI: Maudsley Obsessive Compulsive Inventory 
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the involvement of the THP1 gene in eating disorders. 
Our findings support those of previous studies involving 
Caucasian samples,
6,38 but are somewhat incongruent. In 
the study of Monteleone et al.,
6 although no difference was 
found in the distribution of the TPH1 A218C genotype 
between the patients with BN and controls, the bulimic 
women with the AA genotype exhibited more severe binge 
eating behavior and higher harm avoidance scores. One 
explanation for the discrepancy between our findings and 
theirs may be the different criteria used for the phenotype. 
Considering that between 22% and 37% of women with 
BN reported a history of AN,
39 the significant numbers of 
women with a current diagnosis of BN in their study may 
be classified into the lifetime binge and purging types of 
AN in our hierarchical diagnosis. We need to consider a 
few limitations in this study. The first limitation is the 
small sample size, which can lead to both type I and type 
II errors. It is quite possible that we lacked sufficient statis-
tical power to detect relatively small associations. The re-
duced sample size in the subsidiary analyses focusing on 
obsessionality resulted in a further reduction of statistical 
power. Although our sample size is relatively small for a 
genetic association study, its findings are strengthened by 
the use of rigorous criteria for lifetime diagnosis to define 
the phenotype. Thus, our data demonstrate the need for 
further, large-scale studies in patients with eating disorders. 
The second limitation is that we did not apply a structured 
diagnostic interview to the control subjects. However, we 
do not believe that this could be a confounding factor, as 
the controls were carefully screened for eating disorders 
by means of an interview, as well as for a current and past 
history of psychiatric illnesses, before their participation 
in this study.   
In conclusion, we found a modest increase in the fre-
quency of the AA genotype of the TPH1 gene in the BN 
group, which supports the hypothesis that the TPH1 gene 
contributes to predispose individuals to BN.
6 Based on the 
findings in this study, we cannot exclude the possibility 
that unexplored factors might be involved in the associ-
ation. The results of the present study are informative, but 
require further analysis of the effect of each haplotype on 
the expression of the THP1 gene to clarify the latter’s in-
volvement in BN in a large-scale population with eating 
disorders. 
 
Acknowledgments 
This work was supported by a Korea Research Foundation Grant fund-
ed by the Korean Government (MOEHRD)(KRF-2006-331-E00203) and 
a 2007 Inje University research grant. 
 
REFERENCES 
1. Smith KA, Fairburn CG, Cowen PJ. Symptomatic relapse in bulimia 
nervosa following acute tryptophan depletion. Arch Gen Psychiatry  
1999;56:171-176. 
2. Ono H, Shirakawa O, Kitamura N, Hashimoto T, Nishiguchi N, Nis-
himura A, et al. Tryptophan hydroxylase immunoreactivity is altered by 
the genetic variation in postmortem brain samples of both suicide 
victims and controls. Mol Psychiatry 2002;7:1127-1132. 
3. Nakamura K, Sugawara Y, Sawabe K, Ohashi A, Tsurui H, Xiu Y, et 
al. Late developmental stage-specific role of tryptophan hydroxylase 
1 in brain serotonin levels. J Neurosci 2006;26:530-534. 
4. Kim SW, Park SY, Hwang O. Up-regulation of tryptophan hydroxylase 
expression and serotonin synthesis by sertraline. Mol Pharmacol 2002; 
61:778-785. 
5. Zill P, Büttner A, Eisenmenger W, Möller HJ, Ackenheil M, Bondy B. 
Analysis of tryptophan hydroxylase I and II mRNA expression in the 
human brain: a post-mortem study. J Psychiatr Res 2007;41:168-173. 
6. Monteleone P, Tortorella A, Martiadis V, Serino I, Di Filippo C, Maj 
M. Association between A218C polymorphism of the tryptophan-hy-
droxylase-1 gene, harm avoidance and binge eating behavior in bu-
limia nervosa. Neurosci Lett 2007;421:42-46. 
7. Bulik CM, Bacanu SA, Klump KL, Fichter MM, Halmi KA, Keel P, 
et al. Selection of eating-disorder phenotypes for linkage analysis. Am 
J Med Genet B Neuropsychiatr Genet 2005;139B:81-87. 
8. Halmi KA, Sunday SR, Strober M, Kaplan A, Woodside DB, Fichter 
M, et al. Perfectionism in anorexia nervosa: variation by clinical sub-
type, obsessionality, and pathological eating behavior. Am J Psychiatry 
2000;157:1799-1805. 
9. Fassino S, Amianto F, Gramaglia C, Facchini F, Abbate Daga G. Tem-
perament and character in eating disorders: ten years of studies. Eat 
Weight Disord 2004;9:81-90. 
10. Jonnal AH, Gardner CO, Prescott CA, Kendler KS. Obsessive and 
compulsive symptoms in a general population sample of female twins. 
Am J Med Genet 2000;96:791-796. 
11. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, 
Pollice C, et al. A controlled family study of anorexia nervosa and bu-
limia nervosa: psychiatric disorders in first-degree relatives and effects 
of proband comorbidity. Arch Gen Psychiatry 1998;55:603-610. 
12. Strober M. Personality and symptomatological features in young, non-
chronic anorexia nervosa patients. J Psychosom Res 1980;24:353-359. 
13. Holliday J, Tchanturia K, Landau S, Collier D, Treasure J. Is impaired 
set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry 
2005;162:2269-2275. 
14. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav 
2008;94:121-135. 
15. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. Cogni-
tive inflexibility after prefrontal serotonin depletion. Science 2004; 
304:878-880. 
16. Lai TJ, Wu CY, Tsai HW, Lin YM, Sun HS. Polymorphism screening 
and haplotype analysis of the tryptophan hydroxylase gene (TPH1) 
and association with bipolar affective disorder in Taiwan. BMC Med 
Genet 2005;6:14. 
17. American Psychiatric Association. Diagnostic and Statistical Manual 
of Mental Disorders (4th edition). Washington DC: American Psychi-
atric Association; 1994. 
18. Kaye WH, Lilenfeld LR, Berrettini WH, Strober M, Devlin B, Klump 
KL, et al. A search for susceptibility loci for anorexia nervosa: me-
thods and sample description. Biol Psychiatry 2000;47:794-803. 
19. Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or 
self-report questionnaire? Int J Eat Disord 1994;16:363-370. 
20. Heo SY, Lee MK, Choi YM, Sohn CH, Lee HK, Lee YH. Reliability 
and Factor Analysis of The Korean Version of Eating Disorder Ex-
amination. J Korean Soc Study Obes 2004;13:42-52. 
21. Cloninger CR. Temperament and personality. Curr Opin Neurobiol 
1994;4:266-273. 
22. Sung SM, Kim JH, Yang E, Abrams KY, Lyoo IK. Reliability and 
validity of the Korean version of the Temperament and Character  
 
 
 
 
YR Kim et al. 
www.psychiatryinvestigation.org 49 
Inventory. Compr Psychiatry 2002;43:235-243. 
23. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann 
RL, Hill CL, et al. The Yale-Brown Obsessive-Compulsive Scale I. Devel-
opment, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1111. 
24. Cho DK. The standardization of Maudsley Obsessive Compulsive In-
ventory. Seoul National University Student Review 1985;20:81-90. 
25. Han HM, Yeom TH, Shin YW. The validity and reliability of Beck 
Depression Inventory Korean version. J Korean Neuropsychiatr Assoc 
1986;25:487-500. 
26. Hahn DW, Lee CH, Chon KK. Korean adaptation of Spielberger’s 
STAI (K-STAI). Korean J Health Psychol 1996;1:1-14. 
27. Zhang XD, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. 
Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 
2004;305:217. 
28. Lin YM, Chao SC, Chen TM, Lai TJ, Chen JS, Sun HS. Association 
of functional polymorphisms of the human tryptophan hydroxylase 2 
gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychi-
atry 2007;64:1015-1024. 
29. Nielsen DA, Barral S, Proudnikov D, Kellogg S, Ho A, Ott J, et al. 
TPH2 and TPH1: association of variants and interactions with heroin 
addiction. Behav Genet 2008;38:133-150. 
30. Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, 
et al. Altered 5-HT (2A) receptor binding after recovery from bulimia-
type anorexia nervosa: relationships to harm avoidance and drive for 
thinness. Neuropsychopharmacology 2004;29:1143-1155. 
31. Simansky KJ. Serotonergic control of the organization of feeding and 
satiety. Behav Brain Res 1996;73:37-42. 
32. Jönsson EG, Goldman D, Spurlock G, Gustavsson JF, Nielsen DA, 
Linnoila M, et al. Tryptophan hydroxylase and catechol-O-methyl-
transferase gene polymorphisms: relationships to monoamine metabo-
lite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry 
Clin Neurosci 1997;247:297-302. 
33. Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, 
Levine JM. Decreased serotonin function in bulimia nervosa. Arch 
Gen Psychiatry 1997;54:529-534. 
34. Manuck SB, Flory JD, Ferrell RE, Dent KM, Mann JJ, Muldoon MF. 
Aggression and anger-related traits associated with a polymorphism 
of the tryptophan hydroxylase gene. Biol Psychiatry 1999;45:603-614. 
35. Rujescu D, Giegling I, Bondy B, Gietl A, Zill P, Möller HJ. Associa-
tion of anger-related traits with SNPs in the TPH gene. Mol Psychiatry 
2002;7:1023-1029. 
36. Zaboli G, Gizatullin R, Nilsonne A, Wilczek A, Jönsson EG, Ahne-
mark E, et al. Tryptophan hydroxylase-1 gene variants associate with 
a group of suicidal borderline women. Neuropsychopharmacology 
2006;31:1982-1990. 
37. Wonderlich SA, Connolly KM, Stice E. Impulsivity as a risk factor for 
eating disorder behavior: assessment implications with adolescents. Int 
J Eat Disord 2004;36:172-182. 
38. Han L, Nielsen DA, Rosenthal NE, Jefferson K, Kaye W, Murphy D, 
et al. No coding variant of the tryptophan hydroxylase gene detected 
in seasonal affective disorder, obsessive-compulsive disorder, anorexia 
nervosa, and alcoholism. Biol Psychiatry 1999;45:615-619. 
39. Bulik CM, Sullivan PF, Fear J, Pickering A. Predictors of the develop-
ment of bulimia nervosa in women with anorexia nervosa. J Nerv 
Ment Dis 1997;185:704-707. 
 